Concepedia

David Chian

DC

Statistics

Publications

7

Citations

714

H-Index

7

Active since

2004

Affiliations

Rapt Therapeutics (United States)(Current)

APT Therapeutics (United States)

Sunesis (United States)

David Chian is an author at Rapt Therapeutics (United States) specializing in drug discovery, cancer immunotherapy, and medicine.

Publications per year

2004–2020

7

Publications

7

Polo-like Kinase 2 (PLK2) Phosphorylates α-Synuclein at Serine 129 in Central Nervous System

Kelly J. Inglis, David Chéreau, Elizabeth Brigham et al. · Journal of Biological Chemistry · 2008 · 270 citations · Full text

, , +10

Neurotoxic effects of postnatal thimerosal are mouse strain dependent

Mady Hornig, David Chian, W. Ian Lipkin · Molecular Psychiatry · 2004 · 162 citations

, , +15

Tumors establish resistance to immunotherapy by regulating T<sub>reg</sub>recruitment via CCR4

Lisa A. Marshall, Sachie Marubayashi, Aparna Jorapur et al. · Journal for ImmunoTherapy of Cancer · 2020 · 144 citations · Full text

, , +17

Design of an orally efficacious hydroxyethylamine (HEA) BACE-1 inhibitor in a preclinical animal model

Anh P. Truong, G. Toth, Gary D. Probst et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 48 citations · Full text

, , +7

Discovery of 4-alkylamino-7-aryl-3-cyanoquinoline LRRK2 kinase inhibitors

Albert W. Garofalo, Marc Adler, Danielle L. Aubele et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 34 citations · Full text

, , +11

1–5 of 7